DISCLAIMER — Not financial advice. Educational content only, not an offer or solicitation to buy or sell any security. Biotech and small/mid-cap stocks are highly speculative and volatile and can result in a partial or total loss of capital. Do your own research and consult a licensed advisor where appropriate. / Contenuti a solo scopo informativo e didattico, non costituiscono consulenza finanziaria né offerta o sollecitazione al pubblico risparmio ai sensi delle normative CONSOB e SEC. Le azioni biotech e le small/mid cap sono strumenti altamente speculativi e volatili e possono comportare la perdita parziale o totale del capitale investito. Si raccomanda di effettuare sempre le proprie ricerche e, se necessario, di rivolgersi a un consulente abilitato.

Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker

Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker
Quantum Computing · Tech · Defense
Quantum Leap: The Sector Calculates the Future — and the Profits
Quantum Leap: Il Settore Calcola il Futuro — e i Profitti
IonQ (IONQ), D-Wave (QBTS), Rigetti (RGTI) — Why the Synchronised Rally Is No Accident
$IONQ
$QBTS
$RGTI
Research completed April 17, 2026. Financial data sourced from SEC filings, official company press releases, DARPA materials, and official investor relations pages as of the dates indicated. Analyst targets, valuation multiples, and certain market-dependent figures remain approximate and are flagged where relevant. This report does not incorporate events occurring after April 17, 2026.
Key Catalysts — Active Now
Catalyst Chiave — Attivi Ora
- IONQ: DARPA HARQ contract (networked quantum architectures, diamond interconnects) — April 2026
- IONQ: Photonic interconnect milestone with AFRL — two trapped-ion systems linked over distance
- IONQ: Acquisition of SkyWater Technology (quantum chip foundry) — pending close, expected Q2-Q3 2026
- QBTS: Acquisition of Quantum Circuits, Inc. (gate-model, 99.9% fidelity) — completed
- QBTS: $32.8M in 2026 bookings announced after FY2025 close — already above all FY2025 bookings
- RGTI: Cepheus-1-108Q (108 qubits) now available on QCS platform and Amazon Braket at 99.1% median two-qubit gate fidelity
- RGTI: Performance upgrades to Cepheus-1-108Q targeted through 2026; broader roadmap update expected later in the year
- Macro: risk-on backdrop in mid-April helped high-beta growth and defense-adjacent tech outperform
Executive Summary
Quantum computing is no longer a theoretical exercise. In the span of a few weeks in April 2026, three publicly traded quantum companies — IonQ (IONQ), D-Wave Quantum (QBTS), and Rigetti Computing (RGTI) — produced a synchronised breakout that caught the attention of investors well beyond the specialized tech community. IONQ surged more than 20% in a single session, dragging QBTS and RGTI higher with it, in a coordinated move driven by genuine fundamental catalysts rather than sector hype alone.
The shift in narrative is significant. Until recently, quantum computing was routinely grouped with other “science fiction” technologies: perpetually five to ten years away from commercial relevance, propped up by government grants and investor enthusiasm rather than contracts and revenue. That framing is now outdated. IonQ crossed $100 million in annual GAAP revenue in 2025 — a first for any public quantum company — and is guiding for $225 to $245 million in 2026. D-Wave entered 2026 with more booking momentum than it delivered in all of fiscal 2025. And Rigetti is shipping its 108-qubit Cepheus-1-108Q system to cloud platforms while continuing to position future roadmap updates as central to the next leg of its thesis.
This report dissects what is actually happening beneath the surface of a speculative-looking rally: which contracts are real, which revenue figures are verified, and what distinguishes IonQ’s mature commercial model from the earlier-stage profiles of QBTS and RGTI. It also examines the macro forces converging to accelerate adoption — post-quantum cryptography mandates, Pentagon spending on networked quantum infrastructure, and the growing integration between quantum and AI through platforms like NVIDIA NVQLink.
IONQ FY2025 Revenue
$130M
+202% YoY · FY2026 guide $225-245M
QBTS FY2025 Revenue
$24.6M
+179% YoY · $884.5M cash
RGTI FY2025 Revenue
$7.1M
-34.3% YoY (from $10.8M FY2024) · $589.8M cash
IONQ Cash & Investments
$3.3B
As of Dec 31, 2025 · Source: FY2025 results / investor materials
QBTS 2026 Bookings Announced
$32.8M
Already above FY2025 bookings
RGTI Current System
108Q
Cepheus-1 live · 99.1% median 2Q fidelity
The Technology Stack — What Each Company Actually Builds
IonQ: Trapped-Ion Systems and the Network Play
IonQ operates on trapped-ion technology, which uses individual ytterbium ions suspended in electromagnetic fields as qubits. This architecture delivers exceptionally high gate fidelity — IonQ reports 99.99% two-qubit gate fidelity on its Tempo platform — which means each computational operation has an error rate below one in ten thousand. In practice, this fidelity advantage makes IonQ systems far more useful for real workloads today than lower-fidelity alternatives, even when qubit counts are lower.
The pivotal development of April 2026 was not the DARPA HARQ contract in isolation, but the simultaneous demonstration of photonic interconnection between two independent trapped-ion quantum systems in collaboration with the Air Force Research Laboratory. This is a technically significant milestone because it validates the concept of quantum networking: linking separate quantum processors through photonic channels to create a distributed quantum architecture that scales beyond the physical limits of a single chip. The analogy to the GPU interconnect story — where combining multiple GPUs was central to AI scaling — is not coincidental. IonQ’s CEO Niccolo de Masi has made this comparison directly, and the DARPA HARQ program is explicitly designed to advance heterogeneous, networked quantum computing.
The SkyWater Technology acquisition, pending close and expected in the second or third quarter of 2026, adds a critical manufacturing dimension. SkyWater is a leading U.S.-based trusted foundry, and bringing it in-house means IonQ aims to control more of the stack from fabrication to deployment. For government buyers — particularly defense agencies that require trusted, onshore supply chains — this vertical integration is a commercial differentiator.
D-Wave: Annealing Plus Gate-Model — the Dual Platform
D-Wave occupies a different and in some ways complementary position in the quantum ecosystem. Its Advantage2 annealing system is designed not for universal gate-model computation but for optimization problems: scheduling, logistics, portfolio optimization, and molecular simulation. Annealing quantum computers are well-suited to a specific class of problems that are computationally expensive for classical systems and where a “good enough” solution found very quickly is more valuable than an exact solution found slowly.
What changed the D-Wave story in 2025 and into 2026 was twofold. First, the commercial pipeline for Advantage2 expanded sharply as the system became generally available and enterprise customers began running actual workloads. Second, the acquisition of Quantum Circuits, Inc. transformed D-Wave from a single-architecture company into a dual-platform provider offering both annealing and gate-model systems. Quantum Circuits brings superconducting qubits with built-in error-detection architecture and management has highlighted fidelity above 99.9% in its materials.
The booking velocity in early 2026 reflects genuine enterprise adoption rather than speculative orders. The $20 million Florida Atlantic University system sale and the $10 million, two-year QCaaS agreement with a Fortune 100 company represent anchor contracts that validate the transition from pilot programs to budget-line items. Particularly notable is the €10 million booking tied to an Advantage2 deployment in Lombardy, Italy, which gives the story a tangible European angle.
Rigetti: The Hardware Manufacturer Betting on Scale
Rigetti’s story is the highest-risk and highest-potential of the three, precisely because it depends on successfully executing a roadmap that no one has yet achieved at scale. The company’s chiplet-based superconducting architecture is designed to solve quantum computing’s core scaling problem: individual chips are inherently limited in qubit count by fabrication yield and cross-talk, but modular chiplets can be interconnected to produce larger effective systems. This is the same approach the semiconductor industry used with multi-chip modules, and it is why Rigetti’s FAB-1 — its dedicated quantum manufacturing facility — is viewed as a durable competitive advantage if the roadmap holds.
The Cepheus-1-108Q, now available on the Rigetti Quantum Cloud Services platform and through Amazon Braket, is the current flagship. Its current median two-qubit gate fidelity is 99.1%, with management targeting further improvement to 99.5% later in 2026. That distinction matters: 99.1% is the verified current figure, while 99.5% remains a later-2026 target. Rigetti has also said a broader roadmap update is expected later in 2026, so older references to higher-qubit milestones should be treated as forward-looking rather than as already-confirmed current targets.
The 2025 revenue decline to $7.1 million (from $10.8 million in FY2024) is a genuine concern that deserves to be addressed plainly rather than minimized. Revenue declined because Rigetti shifted its commercial focus toward larger, more strategic system sales while the prior year benefited from a large one-time government contract. The $8.4 million C-DAC order and previously announced Novera demand suggest a recovery path, but the revenue base remains thin relative to the stock’s valuation. Rigetti’s earlier disclosure that it was not initially selected for DARPA QBI Stage B remains a legitimate risk flag.
The Pentagon Factor — Why Defense Contracts Are Reshaping the Sector
The most consequential structural shift in quantum computing in 2026 is the transition from research funding to procurement. Defense agencies — including DARPA and the Air Force Research Laboratory — have moved from grants that fund exploration to contracts and programs that specify deliverables, timelines, and performance benchmarks. This is the difference between a department paying a lab to study something interesting and a procurement office paying a supplier to deliver something specific that will be deployed.
IonQ’s HARQ selection by DARPA is a template for this transition. The Heterogeneous Architectures for Quantum program is not paying IonQ simply to prove that quantum networking is theoretically possible. It is supporting the development of high-speed interconnects capable of linking different quantum modalities into a unified networked architecture. The deliverable is infrastructure. The use case is national security. The timeline is operational, not purely academic.
The Missile Defense Agency SHIELD IDIQ award announced in February 2026 is further evidence of the same pattern. Quantum sensing — one of IonQ’s expansion areas alongside networking and security — remains an area the company is clearly trying to connect to defense workloads. The convergence of quantum computing, sensing, and networking under one platform is a major part of the premium narrative behind IonQ versus peers.
For QBTS and RGTI, the Pentagon opportunity is real but less developed. D-Wave’s systems appear better matched to optimization and logistics use cases, while Rigetti still needs more proof at larger scale before it can credibly claim the same defense relevance as IonQ today.
The Cryptography Angle — Post-Quantum as Commercial Accelerant
Parallel to the military contracting story is a civilian compliance driver that will generate quantum computing demand regardless of the military budget cycle. The National Institute of Standards and Technology published its first post-quantum cryptography standards in 2024, and federal agencies are required to migrate cryptographic infrastructure to PQC-compliant systems on an accelerating timeline. Large institutions now have a practical reason to follow the evolution of quantum hardware even if they are years away from directly deploying large-scale quantum systems.
The connection to the three stocks in this report is direct but indirect. None of IonQ, D-Wave, or Rigetti sells PQC software. What they sell is hardware infrastructure that sits at the center of the long-term security transition narrative: the same advances in quantum computing that increase the pressure on legacy encryption are also what push governments and corporations to invest earlier in quantum readiness.
Quantum Meets AI — The NVIDIA Connection
NVIDIA’s push into AI supercomputer-quantum integration is one of the clearest signals yet that the two highest-profile technology narratives of the cycle are converging. Rigetti has positioned itself within this hybrid AI-quantum discussion, and IonQ has also marketed systems around hybrid AI, HPC, and quantum environments. The commercial promise here is not that quantum replaces GPUs, but that specialized quantum systems eventually slot into workflows that classical accelerators cannot solve efficiently on their own.
Financial Comparison and Valuation Reality
| Metric | IONQ | QBTS | RGTI |
|---|---|---|---|
| FY2025 Revenue | $130M (+202%) ¹ | $24.6M (+179%) ² | $7.1M (-34.3% from $10.8M in FY2024) ³ |
| FY2026 Revenue Guidance | $225-245M ¹ | Not provided | Not provided |
| Commercial Backlog / Bookings | $370M backlog ⁴ | $32.8M announced after FY close ² | C-DAC $8.4M order; Novera demand noted ³ |
| Cash & Investments | $3.3B ¹ | $884.5M ² | $589.8M ³ |
| Gross Margin (FY2025) | ~40.4% ¹ | 82.6% GAAP ² | ~29.6% ($2.1M GP / $7.1M rev) ³ |
| Enterprise Value | >$10B ⁵ | ~$2.5B ⁵ | ~$4.7B ⁵ |
| Price/Sales (Trailing) | ~80x ⁵ | ~230x ⁵ | ~660x ⁵ |
| Two-Qubit Gate Fidelity | 99.99% (Tempo) | 99.9% (QCI materials) | 99.1% current (108Q) · 99.5% target later 2026 |
| Key 2026 Milestone | SkyWater close, HARQ delivery | Commercial conversion of bookings, QCI integration | 108Q performance upgrades; roadmap update later 2026 |
| Primary Defense Exposure | DARPA, AFRL, MDA SHIELD | Emerging | Still needs stronger defense validation |
| Analyst Consensus Target | $65.42 (Moderate Buy) | ~132% upside (Mod Buy) | $33.50 (Strong Buy) |
Sources: ¹ IonQ FY2025 results / official investor materials. Gross margin 40.4% calculated from reported revenue and cost of revenue. ² D-Wave FY2025 results / official press release. ³ Rigetti FY2025 results and April 2026 108-qubit launch materials / official investor relations pages. ⁴ $370M backlog is cited by secondary market sources as tied to the Q4 2025 earnings call; it was not clearly stated in the primary earnings press release reviewed here. Keep as a useful market datapoint, but treat it as secondary and not as a primary-source-confirmed SEC figure. ⁵ Enterprise value, price/sales ratios, and analyst targets are market-price dependent and derived from secondary sources or consensus aggregators. They are retained here for context, but they are approximate and not primary-source figures.
The valuation table above makes one point starkly: all three stocks trade at extraordinary multiples relative to current revenue. This is not unusual for pre-profitability technology companies in early commercial phases, but it does mean that any investment thesis must be built on a credible model of future revenue growth rather than current fundamentals. IonQ has the strongest near-term revenue visibility. QBTS has the most explosive booking acceleration. RGTI has the most aggressive upside narrative if execution improves, but also the thinnest current commercial foundation.
Analyst Targets
IONQ
13 analysts cover IONQ: 8 Strong Buy, 1 Moderate Buy, 4 Hold. Mean target $65.42. These figures are retained because they are useful for reader context, but they remain consensus/aggregator data rather than primary-source company data.
QBTS
Moderate Buy consensus. The target framework is still useful for context, but it should be read as third-party opinion rather than as a verified company metric.
RGTI
Strong Buy consensus. The upside case remains highly execution-dependent, which matters more here than in many other coverage universes because the company is still early in commercial scale-up, not pre-revenue but still commercially thin.
Sentiment
Market Sentiment — Reddit / Stocktwits / X
On retail platforms, IONQ is generally treated as the sector leader and the most institutionally legible story. QBTS tends to attract traders who want stronger balance-sheet support and operating leverage from bookings. RGTI remains the highest-beta expression of the group, with the community generally seeing it as the most asymmetric but also the most fragile if roadmap execution slips.
Disclaimer: All sentiment above reflects comments from non-professional retail traders and social media users. None of the opinions cited above constitute financial advice, analyst recommendations, or institutional views.
Health Score — Merlintrader Framework
Merlintrader Health Score (1-5 scale · Not a buy/sell signal)
4.2
IONQ
3.4
QBTS
2.6
RGTI
Score = 0.3×Balance + 0.3×Catalyst + 0.2×Dilution + 0.1×Liquidity + 0.1×Execution
IONQ: Balance 4/Catalyst 5/Dilution 3/Liquidity 4/Execution 5 · QBTS: Balance 5/Catalyst 3/Dilution 2/Liquidity 5/Execution 3 · RGTI: Balance 4/Catalyst 3/Dilution 2/Liquidity 4/Execution 2
IONQ (4.2/5): Leads on catalyst strength and execution track record. Dilution is a moderate concern given acquisition activity. Balance sheet is solid.
QBTS (3.4/5): Exceptional cash position and gross margins score highly on balance. Dilution history remains a valid caveat, even with the stronger funding position.
RGTI (2.6/5): Cash runway is meaningful, but execution risks are high: revenue declined 34.3% in 2025, the company still needs stronger commercial proof, and the next phase of the roadmap remains central to the thesis.
Bull and Bear Framework
Bull Case
- IonQ delivers on FY2026 revenue and converts defense/networking traction into repeatable infrastructure revenue
- D-Wave converts booking velocity into recurring QCaaS revenue and proves the dual-platform story can scale commercially
- Rigetti materially improves Cepheus-1-108Q performance through 2026 and follows with a credible roadmap update that restores confidence in larger-scale execution
- Hybrid AI-quantum infrastructure becomes a real enterprise budget line rather than a research-side experiment
- Post-quantum cryptography preparedness accelerates budget allocation across government and regulated industries
Bear Case
- IONQ misses FY2026 guidance and the premium multiple compresses fast
- SkyWater integration proves more complex or more dilutive than expected
- QBTS fails to convert bookings into durable revenue at the pace bulls expect
- Rigetti roadmap progress disappoints, leaving the market with a very thin revenue base and a still-speculative valuation
- Risk-on appetite fades and high-multiple frontier tech re-rates lower across the board
What the Market Has Probably Already Priced — and What It Has Not
The synchronized April rally in IONQ, QBTS, and RGTI has likely already priced in the cleanest recent positives: HARQ, photonic interconnect momentum, D-Wave’s booking surge, and the broader appetite for frontier tech. What is much less settled is how those signals convert into medium-term revenue durability, whether SkyWater materially upgrades IonQ’s strategic position after closing, and whether Rigetti’s later-2026 roadmap update can meaningfully improve confidence.
Risks and Red Flags
Dilution remains structural across the group. None of the three is a mature self-funding business, and all rely on capital-market credibility to some degree. Revenue concentration is also real, especially where a small number of large contracts can dominate the annual profile. And technical execution still matters enormously: this sector has punished timelines slips for years, and it will keep doing so.
Disclaimer: This report is produced by Merlintrader (merlintrader.com) for informational and educational purposes only. It does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any security. All data cited in this report is sourced from SEC filings, official company press releases, official investor relations materials, DARPA materials, and other publicly available sources as indicated. Forward-looking statements, analyst price targets, valuation multiples, and revenue guidance figures are conditional projections or third-party estimates and not guarantees of future performance. Contract wins do not guarantee revenue recognition in any specific period. The Merlintrader Health Score is a proprietary editorial framework and is not a buy/sell signal. Readers must conduct their own due diligence and consult a qualified financial advisor before making any investment decision. Merlintrader may hold positions in securities discussed; this will be disclosed separately where relevant. For full legal terms see: merlintrader.com/disclaimer · Condizioni d’uso e Privacy.
Scanner for active traders

Try ChartsWatcher free, then unlock 10% OFF with SAVE10
ChartsWatcher is a real-time scanner for momentum traders: fast movers, unusual volume and rotations — so you can focus on the few tickers that matter right now, instead of watching hundreds of charts.
Start with the free version. When you upgrade, use SAVE10 for 10% OFF your first paid period.
Start free – then use SAVE10
No credit card required to start. Apply SAVE10 when upgrading.
Recommended platform
One platform. All your brokers.
Medved Trader connects multiple brokers in one workspace, with pro charts, hotkeys and fast execution — without changing your broker accounts.
A single cockpit for positions, Level II and multi-broker order routing, built for active day & swing traders.
Get 1 Month Free ➔
Multi-broker workflow + customizable layouts in one platform.